Press Releases
Cleveland Diagnostics, Inc. Raises Over $19 Million in Financing
February 9, 2021
Benesch represented Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, during its Series D round of investing lead by Lyfe Capital which raised over $19 million in financing.
Funds raised will be used to expand commercialization of IsoPSA—the company’s first diagnostic test, designed to enhance early detection of prostate cancer—as well as to expand internal infrastructure and operations to support platform development for other tests, including breast and lung cancer.
The Benesch team included Sean Peppard and Ryan Williams.
Latest News
Benesch Named to U.S. News & World Report’s Best Companies to Work For: Law Firms List for Third Consecutive Year
Benesch is pleased to announce that the firm has been named to U.S. News & World Report’s 2026 Best Companies to Work For: Law Firms list for the third consecutive year. Benesch has earned a place on the list every year since its inception, underscoring the firm’s ongoing commitment to cultivating a positive, high-performing workplace where attorneys and professional staff can build rewarding careers.
Benesch Advises Preferred Vascular Group in Strategic Sale to Surgery Partners
Benesch is pleased to announce that it served as legal counsel to Preferred Vascular Group (PVG) in its recent acquisition …
Benesch Earns Rankings by Vault for Summer Associate Program and Firmwide Inclusion
Benesch is proud to announce that, for the third consecutive year, the firm has been recognized in the Vault rankings for Best Summer Associate Program and has earned new rankings for firmwide inclusion.
Benesch Launches “Legends of Culture” Podcast Series Hosted by Chief Culture Officer Jared Oakes
Benesch is pleased to announce that it has been named Firm of the Year as part of the Legal Sales and Service Organization’s (LSSO) 2026 Leonardo Inghilleri Service Excellence Awards.